PIK3CA as an oncogene in cervical cancer - Wikidata - awgldk - TriplyDB

PIK3CA as an oncogene in cervical cancer

PIK3CA as an oncogene in cervical cancer

http://www.wikidata.org/entity/Q28138126

about

Mutations of PIK3CA in gastric adenocarcinoma PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein Therapeutic Implications of Targeting AKT Signaling in Melanoma The PI3K pathway as drug target in human cancer Downregulation of calcineurin activity in cervical carcinoma Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure.Somatic mutation and gain of copy number of PIK3CA in human breast cancer.PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application Autophagy in malignant transformation and cancer progression Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas Oncogenic mutations of PIK3CA in human cancers Integrated functional, gene expression and genomic analysis for the identification of cancer targets 3q26 amplification is an effective negative triage test for LSIL: a historical prospective study Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.Mutations in PIK3CA are infrequent in neuroblastoma.The Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma.Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study.Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.Constitutive AKT activation in follicular lymphoma.PIK3CA hotspot mutation scanning by a novel and highly sensitive high-resolution small amplicon melting analysis method.Sensitivity of global translation to mTOR inhibition in REN cells depends on the equilibrium between eIF4E and 4E-BP1.Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR.Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway.Up-regulation of PIK3CA promotes metastasis in gastric carcinoma.Akt: a double-edged sword in cell proliferation and genome stability.TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.PIWIL4 regulates cervical cancer cell line growth and is involved in down-regulating the expression of p14ARF and p53.Cancer-specific mutations in PIK3CA are oncogenic in vivo Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed Pten signaling in gliomas.

P2860

Q21261219-E2B31393-FEE2-44C2-A23F-AD574E03F63F Q24304468-9597174E-5568-4454-A0F0-E3804EEFF7FB Q24631438-D9474F5F-2E3F-4F74-A4C3-2EAB65B6AFB3 Q24632283-CC22BF1D-1253-4C1F-8D3A-68448E87D27F Q24795040-49CA7620-BDC2-403D-8F0D-0868D7BFF9C9 Q24799110-1452A526-8EBB-4BE9-A644-E7A3A49C4ACF Q24801684-5446F178-5EFD-4CEE-AE62-9E68DCF0553A Q24803764-82FC6959-A5BC-4045-BD2D-2B13153CBB2E Q24813416-1A355A96-389C-49FE-AA86-8A709B8C7A25 Q26801538-1451D076-D491-4B77-8871-AD9D18264E6E Q27000191-7F30163B-A9E2-4ADC-AEF0-54EE12D28BFF Q27824772-12B012AF-151B-4922-B8AE-C06A96F41EF0 Q27851714-FC37FB76-3E52-4AE8-B827-D92DDB5378A4 Q28071388-FCEC8DFF-829E-41A3-AF6F-9ABF3D069A6B Q28200766-F11D144A-B064-4B65-93B1-FFEB9A9919EC Q28271306-A1FF3ECF-E7EF-42C3-8B4F-96E0C6F9C085 Q28284802-626E59ED-49F3-4E81-9B84-147DCB85D312 Q28475254-BF7C36F9-C38C-4D96-B06C-1B4F248766C9 Q28727452-D9226962-F7D5-4777-91BC-114AB5A1AA44 Q28729079-FCE8B110-49DF-44B0-86E9-113B8BC4E391 Q29547302-B3773B38-D19B-4BA8-B88C-CC9CDAC1DEB6 Q30277065-1465727B-AF32-435A-888D-0E5262C80D4B Q33248957-ABC0F5F0-86CC-4789-A0E6-DE0E461D4146 Q33607950-5E6FA9E4-6910-46A6-8952-DA9D93937D77 Q33690029-8BCEF77F-4272-412E-82EB-F8DD49154660 Q33707662-51C8B46C-7E4D-473F-8C6C-FE72E1C12154 Q34037865-681999EC-8245-4B22-AB28-027F091BC7B9 Q34084868-EFE71C99-1195-4A8A-B5A5-9E94CDA8DF80 Q34117251-0B61D817-D318-48CA-840E-7ADE4963CF6E Q34128087-B9164327-E482-42D2-8750-4E5B3A2C24CB Q34193299-5E946A40-0E34-477A-AB68-60F803601EF3 Q34199061-12A6C7AB-F961-4C22-BC7B-CDF883E45754 Q34213783-A0BD7370-27BF-487F-970D-0185AC8FC04D Q34223641-9170EA61-FEE6-49F0-A694-0CBF749EA3C8 Q34239911-9A5CDC19-973F-4377-8A12-311D62D52F07 Q34266578-6C6D702E-1FE7-4995-BDDC-3A8B94B325EE Q34335169-136242B1-A889-488F-9613-BE5338B4E8A3 Q34508976-00A05EBE-FF79-4042-AB74-E98DF3966AB9 Q34605065-19D6CBC8-6A57-463A-9FB1-7DD71208E0F7 Q34707865-B357CD2E-4F85-494C-8DF9-FB681792BE04

P2860

PIK3CA as an oncogene in cervical cancer

http://www.wikidata.org/entity/Q28138126

description

2000 nî lūn-bûn

@nan

2000 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

PIK3CA as an oncogene in cervical cancer

@ast

PIK3CA as an oncogene in cervical cancer

@en

PIK3CA as an oncogene in cervical cancer

@nl

type

label

PIK3CA as an oncogene in cervical cancer

@ast

PIK3CA as an oncogene in cervical cancer

@en

PIK3CA as an oncogene in cervical cancer

@nl

prefLabel

PIK3CA as an oncogene in cervical cancer

@ast

PIK3CA as an oncogene in cervical cancer

@en

PIK3CA as an oncogene in cervical cancer

@nl

P1433

Q28138126-F82764DA-6C91-473E-8B2A-2CF460373DC0

P1476

Q28138126-302DC310-C736-46E3-997F-8CE451C054DD

P2093

Q28138126-1D4F02C1-1551-44C9-8568-1AE06808A8D7

Q28138126-325EC314-1202-4762-BDF6-D2DDA26C1CEB

Q28138126-66045C9C-06BE-4166-924F-EFA4922BD8AD

Q28138126-73AB0D8D-11CC-4C8D-A22C-9A441ECBBF5A

Q28138126-A1AB36C6-D46F-4494-B6C4-0B932DDD1C3E

Q28138126-A381DBFC-A541-413E-8773-5BD2DD119BE0

Q28138126-C7B0AF80-42A0-4EF8-942E-72171E61CB54

Q28138126-DFBB0610-F423-468C-A68B-8FD4214B2BD1

Q28138126-E5D9A6A3-8CE7-4D56-A7C6-2437ADEA6BFE

Q28138126-FD0896CF-666D-47EC-9397-3440EF6F7152

P2860

Q28138126-0FB5E864-BF03-4A11-BBA1-AF80C034E844

Q28138126-14D64369-D13E-46D1-B033-BEF04EEA9A05

Q28138126-42179749-0D49-48D5-BC66-9E6E8A094BCF

Q28138126-49FB0004-290D-45FA-93A0-BD2E28FB0612

Q28138126-4B0EAC64-5AF9-4116-9848-D3F3B0EA5075

Q28138126-6308B693-C045-492C-B563-D7A2AB11B6D0

Q28138126-731D018B-916D-40B8-A0E3-4DE50BF38EA4

Q28138126-75B11B9B-0B49-4D4E-8875-6A4F1A822598

Q28138126-7E69D3D8-547A-4DF4-A4A1-C8F78D0B98B5

Q28138126-87427E5C-0F13-418A-8830-44DF431D5441

P2888

Q28138126-C50674DD-22EC-42E1-8C32-9A99414FDB30

P304

Q28138126-A301A336-5EE9-48EC-AE18-EC92ED849585

P31

Q28138126-06D6A7DA-25D7-42E4-97AF-C183CF1AF05C

P3181

Q28138126-55DA5F2E-D109-4BE9-A47C-30AB71D7EF4A

P356

Q28138126-643A274B-02C3-4FD6-AB86-09B673DB5B56

P407

Q28138126-BA46F3AC-F7D8-40E2-8111-9F7B12A52C0E

P433

Q28138126-8806C726-C1C6-41C5-A537-A8912AF187CE

P478

Q28138126-DC7776C7-A173-4D11-803B-EF5E03FFA00F

P577

Q28138126-C54A882C-9CBB-4876-A4C5-2E5181A5BE70

P5875

Q28138126-1A2A66C1-1006-4622-AFDC-EFBA87D7F1D4

P6179

Q28138126-CA3A8D43-8C8E-4239-BF4E-3A915F8947E2

P698

Q28138126-6566C2F7-CD1D-4F9F-B379-25D34995A202

P3181

P356

P1433

P1476

PIK3CA as an oncogene in cervical cancer

@en

P2093

C Y Shen

http://www.w3.org/2001/XMLSchema#string

D M Yang

http://www.w3.org/2001/XMLSchema#string

J C Lung

http://www.w3.org/2001/XMLSchema#string

J M Liu

http://www.w3.org/2001/XMLSchema#string

J Whang-Peng

http://www.w3.org/2001/XMLSchema#string

S J Wei

http://www.w3.org/2001/XMLSchema#string

T C Chang

http://www.w3.org/2001/XMLSchema#string

W K Yang

http://www.w3.org/2001/XMLSchema#string

Y C Lin

http://www.w3.org/2001/XMLSchema#string

Y Y Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Signalling through phosphoinositide 3-kinases: the lipids take centre stage

The RNA component of human telomerase

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

Cellular survival: a play in three Akts

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

Comparative genomic hybridization and chromosomal instability in solid tumours.

Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation.

Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase.

Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).

Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase.

P2888

P304

2739-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2809470

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.ONC.1203597

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12467630

http://www.w3.org/2001/XMLSchema#string

P6179

1026226131

http://www.w3.org/2001/XMLSchema#string

P698

10851074

http://www.w3.org/2001/XMLSchema#string